| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |